Predicting methylphenidate response in long-term survivors of childhood cancer: A randomized, double-blind, placebo-controlled, crossover trial

Journal of Pediatric Psychology

Volumn 35, Issue 2, 2010, Pages 144-155

  Conklin, Heather M ^a   Helton, Susan ^a   Ashford, Jason ^a   Mulhern, Raymond K ^f   Reddick, Wilburn E ^b   Brown, Ronald ^c   Bonner, Melanie ^d   Jasper, Bruce W ^a   Wu, Shengjie ^b   Xiong, Xiaoping ^b   Khan, Raja B ^e  

^a Division of Behavioral Medicine   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c TEMPLE UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF TENNESSEE   (United States)

^f NONE

Author keywords

Brain tumor; Leukemia; Methylphenidate; Stimulant medication

Indexed keywords

DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ATTENTION; BRAIN TUMOR; CHILD; CLINICAL TRIAL; COGNITION; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; LEARNING DISORDER; MALE; PREDICTION AND FORECASTING; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SURVIVOR; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ATTENTION; BRAIN NEOPLASMS; CHILD; COGNITION; COMORBIDITY; CROSS-OVER STUDIES; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEARNING DISORDERS; MALE; METHYLPHENIDATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SURVIVORS; TENNESSEE; TREATMENT OUTCOME;

EID: 77149135238     PISSN: 01468693     EISSN: 1465735X     Source Type: Journal    
DOI: 10.1093/jpepsy/jsp044     Document Type: Article

References (63)

1. Achenbach, T. M., & Edelbrock, C. (1991). The Child Behavior Checklist and Revised Child Behavior Profile. Burlington, VT: University Associates in Psychiatry.
2. Aman, M. G. (1996). Stimulant drugs in the developmental disabilities revisited. Journal of Developmental and Physical Disabilities, 8, 347-365.
3. Aman, M. G., Buican, B., & Arnold, L. E. (2003). Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies. Journal of Child and Adolescent Psychopharmacology, 13, 29-40.
4. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, fourth edition. Washington, DC: APA.
5. Arnold, L. (2000). Methylphenidate vs. amphetamine: Comparative review. Journal of Attention Disorders, 3, 200-211.
6. Barkley, R. A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 18, 137-165.
7. Barkley, R. A. (1981). Hyperactive children: A hand-book for parents. New York, NY: Guildford Press.
8. Brown, R. T., Amler, R. W., Freeman, W. S., Perrin, J. M., Stein, M. T., Feldman, H. M., et al. (2005). Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence. Pediatrics, 115, 749-757.
9. Brown, R. T., & Daly, B. (in press). Neuropsychological effects of stimulant medication on children's learning and behaviour. In C. R. Reynolds, & E. Fletcher-Janzen (Eds.), Handbook of child neuropsychology. New York: Wiley.
10. Buitelaar, J. K., Van der Gaag, R. J., Swaab-Barneveld, H., & Kuiper, M. (1995). Predication of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1025-1032.
11. Butler, R. W., Copeland, D. R., Fairclough, D. L., Mulhern, R. K., Katz, E. R., Kazak, A. E., et al. (2008). A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. Journal of Consulting and Clinical Psychology, 76, 367-378.
12. Butler, R.W., & Mulhern, R. K. (2005). Neurocognitive interventions for children and adolescents surviving cancer. Journal of Pediatric Psychology, 30, 65-78.
13. Chabot, R. J., Orgill, A. A., Crawford, G., Harris, M. J., & Serfontein, G. (1999). Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. Journal of Child Neurology, 14, 343-351.
14. Conklin, H. M., Khan, R. B., Reddick, W. E., Helton, S., Brown, R., Howard, S. C., et al. (2007). Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. Journal of Pediatric Psychology, 32, 1127-1139. Conklin, H. M., Lawford, J., Jasper, B. W., Morris, E. B., Howard, S. C., Ogg, S. W., et al. (in press). Side effects of methylphenidate in survivors of childhood cancer: A randomized, double-blind, placebo-controlled trial. Pediatrics.
15. Conners, C. K. (1995). The Conners' Continuous Performance Test. Toronto, Ontario: Multi-Health Systems.
16. Conners, C. K. (2000). Conners' Rating Scales-Revised Technical Manual. North Tonawanda, NY: Multi-Health Systems.
17. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (1994). California Verbal Learning Test-Children's version. Lutz, FL: Psychological Assessment Resources, Inc.
18. Denney, C. B., & Rapport, M. D. (1999). Predicting methylphenidate response in children with ADHD: Theoretical, empirical, and conceptual models. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 393-401.
19. DuPaul, G. J., Barkley, R. A., & McMurray, M. B. (1994). Response of children with ADHD to methylphenidate: Interaction with internalizing symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 894-903.
20. Efron, D., Jarman, F. C., & Barker, M. J. (1998). Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder. Journal of Paediatrics and Child Health, 34, 288-292.
21. Gadow, K. D. (1992). Pediatric psychopharmacotherapy: A review of recent research. Psychiatry, 33, 153-195.
22. Gibson, A. P., Bettinger, T. L., Patel, N. C., & Crismon, M. L. (2006). Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Annals of Pharmacotherapy, 40, 1134-1142.
23. Golden, C. (1978). Stroop Color and Word Test. Wood Dale, IL: Stoelting Company.
24. Grcevich, S., Rowane, W. A., & Marcellino, B. (2001). Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology, 11, 35-41.
25. Greenhill, L. L., Swanson, J. M., Vitiello, B., Davies, M., Clevenger, W., Wu, M., et al. (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 180-187.
26. Gresham, F. M., & Elliott, S. N. (1990). Social Skills Rating System. Circle Pines, MN: American Guidance Service.
27. Grizenko, N., Bhat, M., Schwartz, G., Ter-Stepanian, M., & Joober, R. (2006). Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: A randomized crossover trial. Journal of Psychiatry and Neuroscience, 31, 46-51.
28. Guevara, J., Lozano, P., Wickizer, T., Mell, L., & Gephart, H. (2002). Psychotropic medication use in a population of children who have attention-deficit/ hyperactivity disorder. Pediatrics, 109, 733-739.
29. Haupt, R., Fears, T. R., Robinson, L. L., Mills, J. L., Nicholson, H. S., Zeltzer, L. K., et al. (1994). Educational attainment in long-term survivors of acute lymphoblastic leukemia. Journal of the American Medical Association, 272, 1427-1432.
30. Hechtman, L. (1999). Predictors of long-term outcome in children with attention-deficit/hyperactivity disorder. Pediatric Clinics of North America, 46, 1039-1052.
31. Hermens, D. F., Cooper, N. J., Kohn, M., Clarke, S., & Gordon, E. (2005). Predicting stimulant medication response in ADHD: Evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors. Journal of Integrated Neuroscience, 4, 107-121.
32. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
33. Kimko, H. C., Cross, J. T., & Abernethy, D. R. (1999). Pharmacokinetics and clinical effectiveness of methylphenidate. Clinical Pharmacokinetics, 37, 457-470.
34. Krull, K.R., Brouwers, P., Jain, N., Zhang, L., Bomgaars, L., Dreyer, Z., et al. (2008). Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. Journal of Pediatrics, 152, 101-105.
35. Mohammadi, M. R., & Akhondzade, S. (2007). Pharmacotherapy of attention-deficit/hyperactivity disorder: Nonstimulant medication approaches. Expert Review of Neurotherapeutics, 7, 195-201.
36. Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15, 603-630.
37. Moore, B. D. (2005). Neurocognitive outcomes in survivors of childhood cancer. Journal of Pediatric Psychology, 30, 51-63.
38. Mostow, E. N., Byrne, J., Connelly, R. R., & Mulivhill, J. J. (1991). Quality of life in long-term survivors of CNS tumors of childhood and adolescence. Journal of Clinical Oncology, 9, 592-599.
39. Mulhern, R. K., & Butler, R. W. (2004). Neurocognitive sequelae of childhood cancers and their treatment. Pediatric Rehabilitation, 7, 1-14.
40. Mulhern, R. K., Khan, R. B., Kaplan, S., Helton, S., Christensen, R., Bonner, M., et al. (2004). Short-term efficacy of methylphenidate: A randomized, doubleblind, placebo-controlled trial among survivors of childhood cancer. Journal of Clinical Oncology, 22, 4795-4803.
41. Pfiffner, L. J., & McBurnett, K. (1997). Social skills training with parent generalization: Treatment effects for children with attention deficit disorder. Journal of Consulting and Clinical Psychology, 65, 749-757.
42. Pietrzak, R. H., Mollica, C. M., Maruff, R., & Snyder, P. J. (2006). Cognitive effects of immediate-release methylphenidate in children with attention-deficit/ hyperactivity disorder. Neuroscience and Biobehavioral Review, 30, 1225-1245.
43. Pliszka, S. R. (1998). Comorbidity of attention-deficit/ hyperactivity disorder with psychiatric disorder: An overview. Journal of Clinical Psychiatry, 59, 50-58.
44. Reddick, W. E., White, H., Glass, J. O., Wheeler, G. C., Thompson, S. J., Gajjar, A., et al. (2003). Developmental model relating white matter volume with neurocognitive deficits in pediatric brain tumor survivors. Cancer, 97, 2512-2519.
45. Ris, M. D., & Noll, R. B. (1994). Long-term neurobehavioral outcome in pediatric brain-tumor patients: Review and methodological critique. Journal of Clinical and Experimental Neuropsychology, 16, 21-42.
46. Robison, L. M., Sclar, D. A., Skaer, T. L., & Balin, R. S. (1999). National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clinical Pediatrics, 38, 209-217.
47. Rogers, J., Horrocks, J., Gritton, P. G., & Kernahan, J. (1999). Attentional ability among survivors of leukaemia. Archives of Disease in Childhood, 80, 318-323.
48. Safer, D. J., Zito, J. M., & Fine, E. M. (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics, 98, 1084-1088.
49. Sattler, J. M. (1992). Assessment of Children, Third Edition. La Mesa, CA: San Diego.
50. Schatz, J., Kramer, J. H., Ablin, A., & Matthay, K. K. (2000). Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology, 14, 189-200.
51. Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., et al. (2005). A large, double--blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/ hyperactivity disorder. Psychiatry, 57, 456-463.
52. Spiegler, B.J., Bouffet, F., Greenberg, M. L., Rutka, J. T., & Mabbott, D. J. (2004). Change in neurocognitive functioning after treatment with cranial radiation in childhood. Journal of Clinical Oncology, 15, 706-713.
53. Thompson, S. J., Leigh, L., Christensen, R., Xiong, X., Kun, L. E., Heideman, R. L., et al. (2001). Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. Journal of Clinical Oncology, 19, 1802-1808.
54. Thomson, J. B., & Varley, C. K. (1998). Prediction of stimulant response in children with attention-deficit/ hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 8, 125-132.
55. Weber, P., & Lutschg, J. (2002). Methylphenidate treatment. Pediatric Neurology, 26, 261-266.
56. Wechsler, D. (1991). Wechsler Intelligence Scale for Children-Third Edition. San Antonio, TX: Psychological Corporation.
57. Wechsler, D. (1992). Wechsler Individual Achievement Test. New York: Psychological Corporation.
58. Wechsler, D. (1997). Wechsler Adult Intelligence Scale- Third Edition. San Antonio, TX: Psychological Corporation.
59. Wilkinson, G. S. (1993). The Wide Range Achievement Test. Wilmington, DE: Wide Range, Inc.
60. Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., et al. (2001). Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics, 108, 883-892.
61. Wolraich, M. L., McGuin, L., & Doffing, M. (2007). Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Safety, 30, 17-26.
62. Woodcock, R. W., & Johnson, M. B. (1989). Woodcock- Johnson Tests of Cognitive Ability-Revised. New York, NY: Riverside Publishing Corporation.
63. Zeiner, P., Bryhn, G., Bjercke, C., Truyen, K., & Strand, G. (1999). Response to methylphenidate in boys with attention-deficit hyperactivity disorder. Acta Paediatrica, 88, 298-303.